Trial Profile
A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Darinaparsin (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Alaunos Therapeutics
- 13 Nov 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 18 Jul 2012 Additional trial location (United Kingdom) added as reported by ClinicalTrials.gov.
- 18 Jul 2012 Planned end date changed from 1 May 2008 to 1 Jun 2013 as reported by ClinicalTrials.gov.